Geisler, L.; Hellberg, T.; Lambrecht, J.; Jann, H.; Knorr, J.; Eschrich, J.; Loosen, S.H.; Wree, A.; Hammerich, L.; Krieg, A.;
et al. Inflammatory Cytokines Associated with Diagnosis, Tumor Grade and Prognosis in Patients with Neuroendocrine Tumors. J. Clin. Med. 2022, 11, 6191.
https://doi.org/10.3390/jcm11206191
AMA Style
Geisler L, Hellberg T, Lambrecht J, Jann H, Knorr J, Eschrich J, Loosen SH, Wree A, Hammerich L, Krieg A,
et al. Inflammatory Cytokines Associated with Diagnosis, Tumor Grade and Prognosis in Patients with Neuroendocrine Tumors. Journal of Clinical Medicine. 2022; 11(20):6191.
https://doi.org/10.3390/jcm11206191
Chicago/Turabian Style
Geisler, Lukas, Teresa Hellberg, Joeri Lambrecht, Henning Jann, Jana Knorr, Johannes Eschrich, Sven H. Loosen, Alexander Wree, Linda Hammerich, Andreas Krieg,
and et al. 2022. "Inflammatory Cytokines Associated with Diagnosis, Tumor Grade and Prognosis in Patients with Neuroendocrine Tumors" Journal of Clinical Medicine 11, no. 20: 6191.
https://doi.org/10.3390/jcm11206191
APA Style
Geisler, L., Hellberg, T., Lambrecht, J., Jann, H., Knorr, J., Eschrich, J., Loosen, S. H., Wree, A., Hammerich, L., Krieg, A., Luedde, T., Tacke, F., Roderburg, C., & Mohr, R.
(2022). Inflammatory Cytokines Associated with Diagnosis, Tumor Grade and Prognosis in Patients with Neuroendocrine Tumors. Journal of Clinical Medicine, 11(20), 6191.
https://doi.org/10.3390/jcm11206191